Mast cells are dispensable for normal and activin-promoted wound healing and skin carcinogenesis

Journal of Immunology

Volumn 191, Issue 12, 2013, Pages 6147-6155

  Antsiferova, Maria ^a   Martin, Caroline ^a   Huber, Marcel ^b   Feyerabend, Thorsten B ^c   Förster, Anja ^d   Hartmann, Karin ^d   Rodewald, Hans Reimer ^c   Hohl, Daniel ^b   Werner, Sabine ^a  

^a ETH ZURICH   (Switzerland)

^b UNIVERSITY OF LAUSANNE   (Switzerland)

^c GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^d UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVIN; CRE RECOMBINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CARCINOGENIC ACTIVITY; CELL FUNCTION; CELL LOSS; CHEMICALLY INDUCED DISORDER; CONTROLLED STUDY; EPITHELIZATION; FEMALE; GENE MUTATION; GRANULATION TISSUE; MALE; MAST CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN EXPRESSION; SKIN CARCINOGENESIS; SKIN INJURY; WOUND HEALING;

EID: 84890342639     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1301350     Document Type: Article

References (40)

1. Rodewald, H. R., and T. B. Feyerabend. 2012. Widespread immunological functions of mast cells: fact or fiction? Immunity 37: 13-24.
2. Noli, C., and A. Miolo. 2001. The mast cell in wound healing. Vet. Dermatol. 12: 303-313.
3. Nocka, K., J. C. Tan, E. Chiu, T. Y. Chu, P. Ray, P. Traktman, and P. Besmer. 1990. Molecular bases of dominant negative and loss of function mutations at the murine c-kit/white spotting locus: W37, Wv, W41 and W. EMBO J. 9: 1805-1813.
4. Egozi, E. I., A. M. Ferreira, A. L. Burns, R. L. Gamelli, and L. A. Dipietro. 2003. Mast cells modulate the inflammatory but not the proliferative response in healing wounds. Wound Repair Regen. 11: 46-54.
5. Iba, Y., A. Shibata, M. Kato, and T. Masukawa. 2004. Possible involvement of mast cells in collagen remodeling in the late phase of cutaneous wound healing in mice. Int. Immunopharmacol. 4: 1873-1880.
6. Nauta, A. C., M. Grova, D. T. Montoro, A. Zimmermann, M. Tsai, G. C. Gurtner, S. J. Galli, and M. T. Longaker. 2013. Evidence that mast cells are not required for healing of splinted cutaneous excisional wounds in mice. PLoS One 8: e59167.
7. Weller, K., K. Foitzik, R. Paus, W. Syska, and M. Maurer. 2006. Mast cells are required for normal healing of skin wounds in mice. FASEB J. 20: 2366-2368.
8. Feyerabend, T. B., A. Weiser, A. Tietz, M. Stassen, N. Harris, M. Kopf, P. Radermacher, P. Möller, C. Benoist, D. Mathis, et al. 2011. Cre-mediated cell ablation contests mast cell contribution in models of antibody- and T cell-mediated autoimmunity. Immunity 35: 832-844.
9. Hübner, G., Q. Hu, H. Smola, and S. Werner. 1996. Strong induction of activin expression after injury suggests an important role of activin in wound repair. Dev. Biol. 173: 490-498.
10. Antsiferova, M., M. Huber, M. Meyer, A. Piwko-Czuchra, T. Ramadan, A. S. MacLeod, W. L. Havran, R. Dummer, D. Hohl, and S. Werner. 2011. Activin enhances skin tumourigenesis and malignant progression by inducing a pro-tumourigenic immune cell response. Nat. Commun. 2: 576.
11. Funaba, M., T. Ikeda, K. Ogawa, M. Murakami, and M. Abe. 2003. Role of activin A in murine mast cells: modulation of cell growth, differentiation, and migration. J. Leukoc. Biol. 73: 793-801.
12. Munz, B., H. Smola, F. Engelhardt, K. Bleuel, M. Brauchle, I. Lein, L.W. Evans, D. Huylebroeck, R. Balling, and S. Werner. 1999. Overexpression of activin A in the skin of transgenic mice reveals new activities of activin in epidermal morphogenesis, dermal fibrosis and wound repair. EMBO J. 18: 5205-5215.
13. Bamberger, C., A. Schärer, M. Antsiferova, B. Tychsen, S. Pankow, M. Müller, T. Rülicke, R. Paus, and S. Werner. 2005. Activin controls skin morphogenesis and wound repair predominantly via stromal cells and in a concentrationdependent manner via keratinocytes. Am. J. Pathol. 167: 733-747.
14. Munz, B., G. Hübner, Y. Tretter, C. Alzheimer, and S. Werner. 1999. A novel role of activin in inflammation and repair. J. Endocrinol. 161: 187-193.
15. Junankar, S. R., A. Eichten, A. Kramer, K. E. de Visser, and L. M. Coussens. 2006. Analysis of immune cell infiltrates during squamous carcinoma development. J. Investig. Dermatol. Symp. Proc. 11: 36-43.
16. Werner, S., H. Smola, X. Liao, M. T. Longaker, T. Krieg, P. H. Hofschneider, and L. T. Williams. 1994. The function of KGF in morphogenesis of epithelium and reepithelialization of wounds. Science 266: 819-822.
17. Schindelin, J., I. Arganda-Carreras, E. Frise, V. Kaynig, M. Longair, T. Pietzsch, S. Preibisch, C. Rueden, S. Saalfeld, B. Schmid, et al. 2012. Fiji: an open-source platform for biological-image analysis. Nat. Methods 9: 676-682.
18. Bradley, P. P., D. A. Priebat, R. D. Christensen, and G. Rothstein. 1982. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J. Invest. Dermatol. 78: 206-209.
19. Conti, P., M. Reale, R. C. Barbacane, M. Felaco, A. Grilli, and T. C. Theoharides. 1998. Mast cell recruitment after subcutaneous injection of RANTES in the sole of the rat paw. Br. J. Haematol. 103: 798-803.
20. Jones, C. P., L. G. Gregory, B. Causton, G. A. Campbell, and C. M. Lloyd. 2012. Activin A and TGF-beta promote T(H)9 cell-mediated pulmonary allergic pathology. J. Allergy Clin. Immunol. 129: 1000-1010.e3.
21. Ponvert, C., L. Galoppin, P. Scheinmann, P. Canu, and C. Burtin. 1985. Tissue histamine levels in male and female mast cell deficient mice (W/Wv) and in their littermates (Wv/+, W/+ and +/+). Agents Actions 17: 1-4.
22. Koizumi, T., and J. Hayakawa. 1987. Single-locus control of the mast cell population in mouse skin. Immunogenetics 26: 36-39.
23. Miller, H. R., and A. D. Pemberton. 2002. Tissue-specific expression of mast cell granule serine proteinases and their role in inflammation in the lung and gut. Immunology 105: 375-390.
24. Funaba, M., T. Ikeda, M. Murakami, K. Ogawa, and M. Abe. 2005. Upregulation of mouse mast cell protease-6 gene by transforming growth factorbeta and activin in mast cell progenitors. Cell. Signal. 17: 121-128.
25. Wang, X., J. Ge, E. E. Tredget, and Y. Wu. 2013. The mouse excisional wound splinting model, including applications for stem cell transplantation. Nat. Protoc. 8: 302-309.
26. Kümin, A., M. Schäfer, N. Epp, P. Bugnon, C. Born-Berclaz, A. Oxenius, A. Klippel, W. Bloch, and S. Werner. 2007. Peroxiredoxin 6 is required for blood vessel integrity in wounded skin. J. Cell Biol. 179: 747-760.
27. Schäfer, M., and S. Werner. 2008. Cancer as an overhealing wound: an old hypothesis revisited. Nat. Rev. Mol. Cell Biol. 9: 628-638.
28. Coussens, L. M., W. W. Raymond, G. Bergers, M. Laig-Webster, O. Behrendtsen, Z.Werb, G. H. Caughey, and D. Hanahan. 1999. Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev. 13: 1382-1397.
29. Antsiferova, M., and S. Werner. 2012. The bright and the dark sides of activin in wound healing and cancer. J. Cell Sci. 125: 3929-3937.
30. de Kretser, D. M., R. E. O'Hehir, C. L. Hardy, and M. P. Hedger. 2012. The roles of activin A and its binding protein, follistatin, in inflammation and tissue repair. Mol. Cell. Endocrinol. 359: 101-106.
31. Mukhopadhyay, A., S. Y. Chan, I. J. Lim, D. J. Phillips, and T. T. Phan. 2007. The role of the activin system in keloid pathogenesis. Am. J. Physiol. Cell Physiol. 292: C1331-C1338.
32. Werner, S., and C. Alzheimer. 2006. Roles of activin in tissue repair, fibrosis, and inflammatory disease. Cytokine Growth Factor Rev. 17: 157-171.
33. Otranto, M., V. Sarrazy, F. Bonté, B. Hinz, G. Gabbiani, and A. Desmoulière. 2012. The role of the myofibroblast in tumor stroma remodeling. Cell Adhes. Migr. 6: 203-219.
34. Bernstein, A., B. Chabot, P. Dubreuil, A. Reith, K. Nocka, S. Majumder, P. Ray, and P. Besmer. 1990. The mouse W/c-kit locus. Ciba Found. Symp. 148: 158- 166, discussion 166-172.
35. Zhou, J. S., W. Xing, D. S. Friend, K. F. Austen, and H. R. Katz. 2007. Mast cell deficiency in Kit(W-sh) mice does not impair antibody-mediated arthritis. J. Exp. Med. 204: 2797-2802.
36. Wulff, B. C., A. E. Parent, M. A. Meleski, L. A. DiPietro, M. E. Schrementi, and T. A. Wilgus. 2012. Mast cells contribute to scar formation during fetal wound healing. J. Invest. Dermatol. 132: 458-465.
37. de Souza, D. A., Jr., V. D. Toso, M. R. Campos, V. S. Lara, C. Oliver, and M. C. Jamur. 2012. Expression of mast cell proteases correlates with mast cell maturation and angiogenesis during tumor progression. PLoS One 7: e40790.
38. Muto, S., M. Katsuki, and S. Horie. 2007. Decreased c-kit function inhibits enhanced skin carcinogenesis in c-Ha-ras protooncogene transgenic mice. Cancer Sci. 98: 1549-1556.
39. Gordon, J. R., and S. J. Galli. 1990. Phorbol 12-myristate 13-acetate-induced development of functionally active mast cells in W/Wv but not Sl/Sld genetically mast cell-deficient mice. Blood 75: 1637-1645.
40. Waskow, C., S. Bartels, S. M. Schlenner, C. Costa, and H. R. Rodewald. 2007. Kit is essential for PMA-inflammation-induced mast-cell accumulation in the skin. Blood 109: 5363-5370.